Dr. Ebert is the Chair of Medical Oncology at the Dana-Farber Cancer Institute, the George P. Canellos, MD and Jean S. Canellos Professor of Medicine at Harvard Medical School, a Howard Hughes Medical Institute Investigator, and an Institute Member of the Broad Institute.
Dr. Ebert's research focuses on the molecular basis and treatment of hematologic malignancies, with a particular focus on myelodysplastic syndromes (MDS).
In large-scale genetic analyses of patient samples, his lab has identified somatic mutations that predict prognosis and
response to therapies in MDS patients. His research also focuses on a pre-malignant state for hematologic malignancies, clonal hematopoiesis of indeterminate potential (CHIP), which also increases the risk of cardiovascular disease.
Research Day Agenda
David A. Schwartz, MD, Professor of Medicine and Immunology, Robert W. Schrier Chair of Medicine
|10:05-11:30am||Department of Medicine Rising Stars and Outstanding Early Career Scholar Presentations|
“How to Build and Maintain a Functional Multiciliated Epithelium”
|10:35-11:00am||"Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2"|
Elena Shagisultanova, MD, PhD, Assistant Professor of Medicine, Division of Medical Oncology, 2020 Department of Medicine Rising Star
|11:05-11:30am||“The Relationship between the Gut Microbiome, Inflammation and Metabolic Co-Morbidity in HIV-Infected Populations”|
Catherine Lozupone, PhD, Associate Professor of Medicine, Division of Biomedical Informatics & Personalized Medicine, 2016 Department of Medicine Outstanding Early Career Scholar
|11:30-11:45am||Abstract Awards and Annual Mentoring Award Presentation|
|Noon-1pm||Keynote Address: "Targeted Protein Degradation: Drugging the Undruggable"|
Benjamin L. Ebert, MD, PhD, Harvard Medical School
|1-2pm||Virtual Poster Session|
Visit our virtual poster walk (separate Zoom links) with presentations from graduate students, medical students, residents, fellows, post-docs and junior faculty.